Last reviewed · How we verify
A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis
This is a dose escalation study to test the safety, tolerability and preliminary efficacy of ASN002 in people with moderate to severe atopic dermatitis (AD).
Details
| Lead sponsor | Asana BioSciences |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 36 |
| Start date | Wed Apr 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Dermatitis, Atopic
- Dermatitis Eczema
- Dermatitis, Eczematous
Interventions
- ASN002
- Placebo Oral Tablet
Countries
Canada, United States